AML driven by the rearrangement of the mixed lineage leukemia-1 gene (MLL1 or KMT2Ar) or mutation of the NPM1 requires the chromatin adapter protein menin, encoded by the MEN1 gene, to sustain aberrant leukemogenic gene expression programs [62,63]. This evidence concerns the gene MEN1 and acute myeloid leukemia.